Chengfen Wang
Impact in
- Hepatology top 5%
- Liver physiology and pathology
- Liver Diseases and Immunity
- Liver Disease and Transplantation
- Biochemistry top 10%
- Sulfur Compounds in Biology
Papers in
-
- Liver physiology and pathology 3
- Liver Diseases and Immunity 3
- Hepatocellular Carcinoma Treatment and Prognosis 2
-
- Liver Disease Diagnosis and Treatment 5
- Hepatitis B Virus Studies 3
- Co-authors
- Chuanyong Guo (19 shared papers)Kan Chen (19 shared papers)Weiqi Dai (18 shared papers)Miao Shen (16 shared papers)Jie Lu (16 shared papers)Jingjing Li (17 shared papers)Ping Cheng (15 shared papers)Ling Xu (12 shared papers)
- Journals
- PLoS ONE (3 papers)Biochemical and Biophysical Research Communications (2 papers)Disease Markers (1 paper)Journal of Gastroenterology and Hepatology (1 paper)Hepatology Research (1 paper)
- Partner nations
- China
In The Last Decade
Chengfen Wang
21 papers receiving 978 citations
Peers
Comparison fields: 5 of 90
- Hepatology 224
- Biochemistry 78
- Clinical Biochemistry 69
- Epidemiology 263
- Biochemistry 48
Countries citing papers authored by Chengfen Wang
This map shows the geographic impact of Chengfen Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chengfen Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chengfen Wang more than expected).
Fields of papers citing papers by Chengfen Wang
This network shows the impact of papers produced by Chengfen Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chengfen Wang. The network helps show where Chengfen Wang may publish in the future.
Co-authors
The 25 scholars most cited alongside Chengfen Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 21 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 105 | |
| 2 | 2014 | 95 | |
| 3 | 2013 | 82 | |
| 4 | 2013 | 77 | |
| 5 | 2019 | 60 | |
| 6 | 2014 | 59 | |
| 7 | 2014 | 58 | |
| 8 | 2013 | 56 | |
| 9 | 2014 | 50 | |
| 10 | 2014 | 38 | |
| 11 | 2018 | 38 | |
| 12 | 2017 | 38 | |
| 13 | 2014 | 36 | |
| 14 | 2014 | 32 | |
| 15 | 2018 | 31 | |
| 16 | 2014 | 28 | |
| 17 | 2015 | 26 | |
| 18 | 2015 | 25 | |
| 19 | 2014 | 23 | |
| 20 | 2013 | 22 |
About Chengfen Wang
Chengfen Wang is a scholar working on Hepatology, Epidemiology, Molecular Biology, Oncology and Biochemistry, having authored 21 papers that have together received 989 indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (5 papers), Hepatitis B Virus Studies (3 papers), Liver physiology and pathology (3 papers), Liver Diseases and Immunity (3 papers), Sulfur Compounds in Biology (2 papers), Hepatocellular Carcinoma Treatment and Prognosis (2 papers), Endoplasmic Reticulum Stress and Disease (1 paper) and Adenosine and Purinergic Signaling (1 paper). The work is most often cited by research in Hepatology (224 citations), Biochemistry (78 citations), Clinical Biochemistry (69 citations), Epidemiology (263 citations) and Biochemistry (48 citations). Chengfen Wang has collaborated with scholars based in China. Frequent co-authors include Chuanyong Guo, Kan Chen, Weiqi Dai, Miao Shen, Jie Lu, Jingjing Li, Ping Cheng, Ling Xu, Fan Wang and Yingqun Zhou. Their work appears in journals such as PLoS ONE, Biochemical and Biophysical Research Communications, Disease Markers, Journal of Gastroenterology and Hepatology and Hepatology Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.